| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.00031 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.00018 | 1 |